[1]
Houpe, J. et al. 2022. The utility of frequent laboratory monitoring for patients on tumor necrosis factor-alpha inhibitors in dermatology. Kansas Journal of Medicine. 15, 2 (Jun. 2022), 212–214. DOI:https://doi.org/10.17161/kjm.vol15.16973.